Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)

By Artac Mehmet  

Breast Cancer, Vol. 20, Iss. 2, 2013-04 ,pp. : 174-180

Springer Publishing Company

Access to resources Recommend Favorite

Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine

By Geva Shahar   Lazarev Irena   Geffen David Barry   Ariad Samuel  

Journal of Chemotherapy, Vol. 25, Iss. 3, 2013-06 ,pp. : 176-180

Maney Publishing

Access to resources Recommend Favorite

Surgical Removal of the Primary Tumor Increases Overall Survival in Patients With Metastatic Breast Cancer: Analysis of the 1988–2003 SEER Data

By Gnerlich Jennifer   Jeffe Donna   Deshpande Anjali   Beers Courtney   Zander Christina   Margenthaler Julie  

Annals of Surgical Oncology, Vol. 14, Iss. 8, 2007-08 ,pp. : 2187-2194

Springer Publishing Company

Access to resources Recommend Favorite

Correlation between overall survival and other endpoints in clinical trials of second-line chemotherapy for patients with advanced gastric cancer

By Shitara Kohei   Matsuo Keitaro   Muro Kei   Doi Toshihiko   Ohtsu Atsushi  

Gastric Cancer, Vol. 17, Iss. 2, 2014-04 ,pp. : 362-370

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine monotherapy in patients with anthracycline-and taxane-pretreated metastatic breast cancer

By Lee S.-H.   Lee J.   Park J.   Park S.   Lee K.-E.   Lee S.   Nam E.   Park J.   Kim K.   Jung C.   Park Y.   Yoon S.   Kang W.   Lee M.   Park K.   Im Y.-H.  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 223-231

Humana Press, Inc

Access to resources Recommend Favorite